Rahman M Masudur, Kibria Md Golam, Sultana Nigar, Akhter Mahfuza, Begum Hasina, Haque Md Ahshanul, Haque Rashidul, Sarker Shafiqul Alam, Ahmed Faruque, Hasan Mahmud
Department of Gastroenterology Sheikh Russel National Gastroliver Institute and Hospital Dhaka Bangladesh.
Department of Gastroenterology Delta Medical College and Hospital Dhaka Bangladesh.
JGH Open. 2020 Nov 24;5(1):64-72. doi: 10.1002/jgh3.12448. eCollection 2021 Jan.
As the interrelationship between , metabolic syndrome (MetS), and non-alcoholic fatty liver disease (NAFLD) is controversial, we undertook a community-based study with the aim to find the seroprevalence of and its relationship with MetS and NAFLD.
This door-to-door survey was conducted among the adult subjects (≥18 years) of two villages (Charcharia of Dhaka district and Kharrah of Munshiganj district) of Bangladesh. Interviews using a structured questionnaire, clinical examination, anthropometric measurements, ultrasonogram of the liver, and biochemical tests were performed.
Of 1021 subjects, 781 responded (76.49%), and 767 were included in the final analysis (mean age 40.35 ± 15.56 years; female 63.5%). Anti- antibodies were found in 418 of 767 (54.5%). There were no serostatus association with MetS and diabetes mellitus (DM) in univariate or multivariate analysis (all > 0.05). However, seropositive subjects had lower systolic blood pressure (odds ratio [OR] = -2.95 [-5.58, -0.32]) and low density lipoprotein -cholesterol (OR -7.79 [-15, -0.57]) compared to seronegative subjects in the linear regression model. Seronegativity of was associated with NALFD in univariate ( = 0.007) but not multivariate analysis ( = 0.086). There were no differences in the frequency of seropositivity among the participants with nonobese compared to obese NAFLD (19/42 [45%] 43/99 [43.4%], = 0.844).
In a rural community of Bangladesh, about 55% of the population were seropositive, which was more common among the underweight than normal or obese subjects. However, there was no relationship observed between seroprevalence and MetS, DM, or NAFLD.
由于[具体内容]、代谢综合征(MetS)和非酒精性脂肪性肝病(NAFLD)之间的相互关系存在争议,我们开展了一项基于社区的研究,旨在确定[具体内容]的血清流行率及其与MetS和NAFLD的关系。
在孟加拉国两个村庄(达卡区的查尔查里亚村和蒙希甘杰区的卡拉村)的成年受试者(≥18岁)中进行了这项挨家挨户的调查。使用结构化问卷进行访谈、临床检查、人体测量、肝脏超声检查和生化检测。
1021名受试者中,781人做出回应(76.49%),767人纳入最终分析(平均年龄40.35±15.56岁;女性占63.5%)。767人中418人(54.5%)检测出抗[具体抗体]抗体。单因素或多因素分析中,[具体内容]血清状态与MetS和糖尿病(DM)均无关联(所有P>0.05)。然而,在线性回归模型中,与血清阴性受试者相比,血清阳性受试者的收缩压较低(比值比[OR]= -2.95[-5.58,-0.32])和低密度脂蛋白胆固醇较低(OR -7.79[-15,-0.57])。单因素分析中[具体内容]血清阴性与NAFLD相关(P = 0.007),但多因素分析中无相关性(P = 0.086)。与肥胖NAFLD参与者相比,非肥胖NAFLD参与者的[具体内容]血清阳性频率无差异(19/42[45%]对43/99[43.4%],P = 0.844)。
在孟加拉国的一个农村社区,约55%的人口[具体内容]血清呈阳性,在体重过轻的人群中比正常或肥胖人群更常见。然而,未观察到[具体内容]血清流行率与MetS、DM或NAFLD之间存在关联。